TELA Bio, Inc.
NASDAQ:TELA
3.075 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 16.091 | 16.603 | 16.998 | 15.052 | 14.494 | 11.909 | 11.622 | 11.159 | 10.406 | 8.231 | 8.374 | 7.654 | 7.558 | 5.877 | 5.667 | 5.313 | 3.507 | 3.726 | 4.864 | 3.973 | 3.303 | 3.306 | 2.427 | 2.212 | 1.818 | 1.818 |
| Cost of Revenue
| 5.018 | 5.267 | 5.374 | 4.663 | 4.293 | 4.011 | 3.446 | 3.84 | 3.856 | 3.232 | 2.715 | 3.052 | 2.471 | 2.412 | 2.005 | 2.026 | 1.422 | 1.526 | 1.901 | 1.369 | 1.396 | 1.508 | 1.399 | 0.845 | 1.228 | 1.228 |
| Gross Profit
| 11.073 | 11.336 | 11.624 | 10.389 | 10.201 | 7.898 | 8.176 | 7.319 | 6.55 | 4.999 | 5.659 | 4.602 | 5.087 | 3.465 | 3.662 | 3.287 | 2.085 | 2.2 | 2.963 | 2.604 | 1.907 | 1.798 | 1.028 | 1.367 | 0.59 | 0.59 |
| Gross Profit Ratio
| 0.688 | 0.683 | 0.684 | 0.69 | 0.704 | 0.663 | 0.703 | 0.656 | 0.629 | 0.607 | 0.676 | 0.601 | 0.673 | 0.59 | 0.646 | 0.619 | 0.595 | 0.59 | 0.609 | 0.655 | 0.577 | 0.544 | 0.424 | 0.618 | 0.325 | 0.325 |
| Reseach & Development Expenses
| 2.323 | 2.393 | 2.685 | 2.368 | 2.514 | 2.052 | 2.726 | 2.102 | 2.102 | 2.007 | 1.725 | 1.409 | 1.93 | 1.679 | 1.163 | 1.201 | 0.979 | 0.912 | 0.921 | 0.516 | 1.055 | 1.659 | 0.977 | 1.044 | 1.159 | 1.159 |
| General & Administrative Expenses
| 3.621 | 3.829 | 4.053 | 3.728 | 3.472 | 3.634 | 3.242 | 3.532 | 3.63 | 3.458 | 3.275 | 3.462 | 2.966 | 2.756 | 2.869 | 2.607 | 2.149 | 2.518 | 2.486 | 1.208 | 1.205 | 1.324 | 1.533 | 1.399 | 0.984 | 0.984 |
| Selling & Marketing Expenses
| 16.699 | 17.52 | 17.164 | 14.474 | 14.577 | 13.466 | 11.647 | 11.172 | 11.055 | 9.378 | 8.313 | 6.948 | 7.502 | 6.299 | 6.377 | 6.342 | 4.123 | 5.269 | 5.382 | 4.736 | 3.947 | 3.995 | 4.016 | 3.608 | 3.011 | 3.011 |
| SG&A
| 20.32 | 21.349 | 21.217 | 18.202 | 18.049 | 17.1 | 14.889 | 14.704 | 14.685 | 12.836 | 11.588 | 10.41 | 10.468 | 9.055 | 9.246 | 8.949 | 6.272 | 7.787 | 7.868 | 5.944 | 5.152 | 5.319 | 5.549 | 5.007 | 3.995 | 3.995 |
| Other Expenses
| 0.301 | 0.497 | 0.733 | 0.558 | 0.87 | 0.473 | 0.634 | -0.195 | -0.342 | -0.107 | -0.043 | -0.127 | -0.08 | 0.022 | -0.14 | 0.058 | -0.031 | 0.158 | 0.179 | 0.055 | 0.027 | 0.09 | 0.026 | 0.01 | 0 | 0 |
| Operating Expenses
| 22.643 | 23.742 | 23.902 | 20.57 | 20.563 | 19.152 | 17.615 | 16.806 | 16.787 | 14.843 | 13.313 | 11.819 | 12.398 | 10.734 | 10.409 | 10.15 | 7.251 | 8.699 | 8.789 | 6.46 | 6.207 | 6.978 | 6.526 | 6.051 | 5.674 | 5.674 |
| Operating Income
| -11.57 | -12.406 | -12.278 | -10.181 | -10.362 | -11.254 | -9.439 | -9.487 | -10.237 | -9.844 | -7.654 | -7.217 | -7.311 | -7.269 | -6.747 | -6.863 | -5.166 | -6.499 | -5.826 | -3.856 | -4.3 | -5.18 | -5.498 | -2.524 | -4.88 | -4.88 |
| Operating Income Ratio
| -0.719 | -0.747 | -0.722 | -0.676 | -0.715 | -0.945 | -0.812 | -0.85 | -0.984 | -1.196 | -0.914 | -0.943 | -0.967 | -1.237 | -1.191 | -1.292 | -1.473 | -1.744 | -1.198 | -0.971 | -1.302 | -1.567 | -2.265 | -1.141 | -2.685 | -2.685 |
| Total Other Income Expenses Net
| -1.03 | 6.745 | -0.612 | 0.558 | 0.87 | -0.773 | -0.54 | -1.227 | -2.504 | -1.018 | -0.043 | -0.127 | -0.08 | 0.022 | -0.14 | 0.058 | -0.031 | 0.158 | 0.178 | 0.089 | -0.047 | 0.126 | -1.128 | 2.187 | -0.568 | -0.568 |
| Income Before Tax
| -12.6 | -5.661 | -12.89 | -10.957 | -10.79 | -12.027 | -9.979 | -10.714 | -12.741 | -10.862 | -8.619 | -8.266 | -8.255 | -8.136 | -7.79 | -7.703 | -6.081 | -7.22 | -6.532 | -4.666 | -5.261 | -5.966 | -7.391 | -2.806 | -5.448 | -5.448 |
| Income Before Tax Ratio
| -0.783 | -0.341 | -0.758 | -0.728 | -0.744 | -1.01 | -0.859 | -0.96 | -1.224 | -1.32 | -1.029 | -1.08 | -1.092 | -1.384 | -1.375 | -1.45 | -1.734 | -1.938 | -1.343 | -1.174 | -1.593 | -1.805 | -3.045 | -1.269 | -2.997 | -2.997 |
| Income Tax Expense
| 0 | 0.191 | -4.651 | 1.334 | 1.298 | 2.019 | -0.207 | 1.227 | 0.607 | 1.018 | -6.272 | 0.668 | 0.653 | 0.771 | 0.624 | 0.817 | 0.738 | 0.905 | 0.915 | 0.954 | 0.941 | 1.002 | 0.791 | 0.319 | 1.003 | 3.974 |
| Net Income
| -12.6 | -5.661 | -12.89 | -10.957 | -10.79 | -14.046 | -9.772 | -11.941 | -13.348 | -11.88 | -8.619 | -8.266 | -8.255 | -8.136 | -7.79 | -7.703 | -6.081 | -7.22 | -6.532 | -4.666 | -5.261 | -5.966 | -7.391 | -2.806 | -6.451 | -9.422 |
| Net Income Ratio
| -0.783 | -0.341 | -0.758 | -0.728 | -0.744 | -1.179 | -0.841 | -1.07 | -1.283 | -1.443 | -1.029 | -1.08 | -1.092 | -1.384 | -1.375 | -1.45 | -1.734 | -1.938 | -1.343 | -1.174 | -1.593 | -1.805 | -3.045 | -1.269 | -3.549 | -5.184 |
| EPS
| -0.51 | -0.23 | -0.53 | -0.45 | -0.46 | -0.73 | -0.51 | -0.71 | -0.92 | -0.82 | -0.59 | -0.57 | -0.57 | -0.56 | -0.54 | -0.53 | -0.53 | -0.63 | -1.07 | -0.44 | -0.81 | -0.92 | -1.14 | -0.43 | -21.89 | -31.98 |
| EPS Diluted
| -0.51 | -0.23 | -0.53 | -0.45 | -0.46 | -0.73 | -0.51 | -0.71 | -0.92 | -0.82 | -0.59 | -0.57 | -0.57 | -0.56 | -0.54 | -0.53 | -0.53 | -0.63 | -1.07 | -0.44 | -0.81 | -0.92 | -1.14 | -0.43 | -21.89 | -31.98 |
| EBITDA
| -11.321 | -12.172 | -12.117 | -9.623 | -9.492 | -10.781 | -8.805 | -9.477 | -10.579 | -9.797 | -7.697 | -7.344 | -7.391 | -7.247 | -6.887 | -6.805 | -5.197 | -6.341 | -5.647 | -3.654 | -4.132 | -4.944 | -5.326 | -4.514 | -4.409 | -4.409 |
| EBITDA Ratio
| -0.704 | -0.733 | -0.713 | -0.639 | -0.655 | -0.905 | -0.758 | -0.849 | -1.017 | -1.19 | -0.919 | -0.959 | -0.978 | -1.233 | -1.215 | -1.281 | -1.482 | -1.702 | -1.161 | -0.92 | -1.251 | -1.495 | -2.194 | -2.041 | -2.426 | -2.426 |